glp 1 agonist vs analog GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes glp-1_analogs [TUSOM | Pharmwiki]

Are there specific cancer types I should be more concerned about with these medications

In Europe, Germany is projected to lead the regional market by 2030, and Sweden is the fastest-growing market, with a projected revenue of $855.6 million USD by 2030

Direct effects of GLP-1 receptor agonism on the heart is likely not a major contributor

Healthcare utilization, mortality, and cardiovascular events following GLP1-RA initiation in chronic kidney disease

The Ozempic lawsuit, filed against pharmaceutical giants Novo Nordisk and Eli Lilly, alleged that the drugs, both Glucagon-like peptide 1 (GLP-1) agonists, caused severe gastrointestinal issues.

[DOI] [PubMed] [Google Scholar] 113.Margulies K.B., Hernandez A.F., Redfield M.M., Givertz M.M., Oliveira G.H., Cole R